July 23, 2014 3:51 AM ET

Biotechnology

Company Overview of Immulogic Pharmaceutical Corp.

Company Overview

As of August 1999, Immulogic Pharmaceutical Corp. went out of business. Immulogic Pharmaceutical Corp. operates as a biopharmaceutical company that develops products with a primary emphasis on the diagnosis and treatment of allergies and on the immunological treatment of addiction. The company was founded in 1997 and is based in Waltham, Massachusetts.

610 Lincoln Street

Suite 300

Waltham, MA 02154

United States

Founded in 1997

Phone:

781-466-6000

Fax:

781-466-6010

Key Executives for Immulogic Pharmaceutical Corp.

Immulogic Pharmaceutical Corp. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
TocopheRx United States
Maven Biotechnologies, LLC United States
ReVas United States
Discovery Genomics, Inc. United States
Matritech, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Immulogic Pharmaceutical Corp., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.